Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of Psychiatric Research|February 10, 2024
Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosisHumza Haroon, Ada Man-Choi Ho, Vinod K Gupta, et al.
Brain, Behavior, and Immunity|February 4, 2025
Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitisJacob Ahlberg Weidenfors, Vytautas Griška, Xueqi Li, et al.
The American Journal of Psychiatry|April 1, 2025
Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in SchizophreniaFunda Orhan, Susmita Malwade, Neda Khanlarkhani, et al.
Brain, Behavior, and Immunity|October 22, 2013
Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acidXi-Cong Liu, Maria Holtze, Susan B Powell, et al.
Brain, Behavior, and Immunity|November 30, 2024
Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responsesXueqi Li, Arvid Edén, Susmita Malwade, et al.
Journal of Psychiatry & Neuroscience : JPN|December 3, 2014
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathwayLilly Schwieler, Markus K Larsson, Elisabeth Skogh, et al.
Translational Psychiatry|June 6, 2022
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patientsPei Shang, Ada Man-Choi Ho, Maximilian Tufvesson-Alm, et al.
Molecular Psychiatry|May 26, 2022
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophreniaKärt Mätlik, Daniel R Garton, Ana R Montaño-Rodríguez, et al.
Molecular Psychiatry|May 12, 2021
GRK3 deficiency elicits brain immune activation and psychosisCarl M Sellgren, Sophie Imbeault, Markus K Larsson, et al.
Nature Communications|November 4, 2022
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophreniaJessica Gracias, Funda Orhan, Elin Hörbeck, et al.
Pageof 6